4–5 Dec 2025
Bahir Dar, Ethiopia
Africa/Addis_Ababa timezone

Session

Oral Presentation

4 Dec 2025, 14:00
Bahir Dar, Ethiopia

Bahir Dar, Ethiopia

Conveners

Oral Presentation: 2

  • Awraris Hailu (Debre Berhan University)
  • Walelign Aleminew

Oral Presentation: 1

  • Gizew Asres (Amhara Public Health Institute)
  • Gedefaw Abeje (Bahir Dar University)

Oral Presentation: 3

  • Amare W.
  • Tadesse Hailu (Bahir Dar University)

Oral Presentation: 6

  • Banchiamlak Tegegne (Amhara Public Health Institute)
  • Mulat Yimer

Oral Presentation: 5

  • Getenet G.
  • Alemtsehay Mekonnen (Bahir Dar University)

Oral Presentation: 4

  • Gizew Asres (Amhara Public Health Institute)
  • Gedefaw Abeje (Bahir Dar University)

Oral Presentation: 9

  • Telake Azale (University of Gondar)
  • Desalew Tewabe (Amhara Public Health Institute)
  • Eleni Admasu

Oral Presentation: 8

  • Mulusew Andualem (Bahir Dar University)
  • Getasew Mulat (Amhara Public Health Institute)

Oral Presentation: 7

  • Bayeh Abera (Bahir Dar University)
  • Negese Sewagegn Semie (Amahara Public Health Institute)

Oral Presentation: 12

  • Ashagrie .
  • Yonan M.
  • Samueal D.
  • Dereje .

Oral Presentation: 11

  • Amha Admasie (Bahir Dar University, School of Public Health)
  • Betelhem Belete (Amhara Public Health Institute)

Oral Presentation: 10

  • Girum Meseret Ayenew (Amhara Public Health Institute)
  • Yeshalem Mulugeta Demilew (Bahir Dar University)

Presentation materials

There are no materials yet.
Mekuanint Geta (CDT-Africa, College of Health Sciences, Addis Ababa University, Ethiopia and Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Ethiopia)
04/12/2025, 14:00
Health System Strengthening and Service Access in Crisis Settings
Oral Presentation

Background: Despite the availability of an effective vaccine, the global prevalence of chronic hepatitis B (CHB) in children was estimated to range from 1.3 to 3.4%. In Ethiopia, the estimated seroprevalence of CHB in children under five years old was 2.21%.
Objective: This study aimed to assess the prevalence of breakthrough hepatitis B virus (HBV) infection and its associated...

Building timetable...